SygeLIX(TBF Genie Tissulaire)

N/A

Report date: 2022/12/08 20:00:49

Base Information

Drug NameSygeLIX(TBF Genie Tissulaire)
Drug Alias NameSygeLIX-FSygeLIX-GWharton's jelly
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRectal Fistula
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTbf Genie Tissulaire
China Registration ClassN/A

Develop Information

Active CompaniesTbf Genie Tissulaire
Inactive CompaniesN/A
Active IndicationsRectal Fistula
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A